ProShare Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.3M Sell
503,976
-153,057
-23% -$10.1M 0.05% 197
2026
Q1
$46.8M Sell
657,033
-147,490
-18% -$11.6M 0.07% 166
2025
Q4
$66M Buy
804,523
+211,081
+36% +$16.4M 0.12% 165
2025
Q3
$44.6M Sell
593,442
-131,414
-18% -$9.8M 0.09% 176
2025
Q2
$53.7M Buy
724,856
+49,924
+7% +$3.48M 0.11% 163
2025
Q1
$54.5M Buy
674,932
+75,732
+13% +$6.51M 0.12% 157
2024
Q4
$46.8M Buy
599,200
+97,666
+19% +$8.3M 0.11% 161
2024
Q3
$47.1M Buy
501,534
+36,093
+8% +$3.03M 0.12% 152
2024
Q2
$36.3M Sell
465,441
-45,480
-9% -$3.71M 0.1% 176
2024
Q1
$46.4M Buy
510,921
+91,483
+22% +$7.61M 0.12% 149
2023
Q4
$32.4M Sell
419,438
-72,670
-15% -$5.09M 0.1% 200
2023
Q3
$33.5M Buy
492,108
+74,949
+18% +$5.45M 0.1% 184
2023
Q2
$33.9M Buy
417,159
+358,618
+613% +$28.6M 0.1% 180
2023
Q1
$4.8M Buy
+58,541
New +$4.18M 0.01% 488

Other funds holding GEHC

ProShare Advisors's GEHC Position: Q2 2026 in Review

ProShare Advisors reduced its GE HealthCare (GEHC) stake by 23% in Q2 2026, selling an estimated $10.1M and leaving 503,976 shares worth $32.3M. The position accounts for 0.05% of the portfolio, ranked #197.

ProShare Advisors first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $66M in Q4 2025. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • ProShare Advisors held 503,976 shares of GE HealthCare worth $32.3M as of Q2 2026.
  • ProShare Advisors sold 153,057 GE HealthCare shares in Q2 2026, an estimated $10.1M.
  • GE HealthCare made up 0.05% of ProShare Advisors's portfolio in Q2 2026, its #197 holding.
  • ProShare Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • ProShare Advisors's GE HealthCare position peaked at $66M in Q4 2025.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.